In September of 2019, the Food & Drug Administration (FDA) announced extremely popular and prescribed anti-acid drug Zantac, along with ranitidine, contained dangerously high levels of a molecule known as N-nitrosodimethylamine (NDMA). NDMA is a probable carcinogen and the levels found in the drug were between 3000 and 26,000 times the daily allowable intake limit established by the FDA.
Evidence set forth by the citizen’s petition to the FDA by the pharmacy, Valisure, made a convincing case that Zantac recalls were necessary immediately. In the months after, testing has been ongoing by the FDA to confirm Valisure’s findings and on April 1, 2020, the FDA announced it was asking all Zantac and Ranitidine to be removed from production, the market place, and requested users to properly destroy their Zantac heartburn medication. Without using the word recall, it is effectively a recall to the heartburn prescription medication for which 25 million scripts were written in 2018 alone.
Contact the Willis law firm today to discuss filing a Zantac cancer lawsuit if you have taken Zantac and been diagnosed with cancer. Our dangerous drug lawyers offer a free consultation to review your claim and advise you on your best legal course of action.
Table of Contents
What Types of Cancer has Zantac been Linked to?
Though the medical research is in its infancy, it appears that certain cancers are related to one’s ingestion of Zantac that possibly contained the cancer-causing ingredient known as NDMA. Those Zantac cancers include:
- Bladder Cancer
- Stomach / Gastric Cancer
- Pancreatic Cancer
- Kidney Cancer
- Colorectal Cancer
- Uterine Cancer
- Liver Cancer
- Intestinal Cancer
- Bowel Cancer
- Esophageal Cancer
- And possibly others
Zantac was first marketed and sold in the United States in 1983. It has been enormously successful and was the first prescription drug to reach over a billion dollars in sales. Until the latest developments, Zantac was still quite commonly prescribed all the way from infant age to elderly adults dealing with acid reflux, heartburn, and a variety of stomach ulcer and acid-related symptoms. Ranitidine, the generic form, is sold by many brands under their own labels such as Walmart, Walgreens, and CVS and is the same active medication as Zantac. Both are unsafe due to the way the drug breaks down in any sort of higher temperature environment.
Whether it is elevated temperatures during production, distribution in trucks or ships, sitting in a hot car, or warm body temperatures as the drug makes it way through the digestive system, ranitidine breaks down and reacts with the temperatures and acid to create toxic levels of NDMA that over time and high levels of exposure, could cause life-threatening cancers like bladder, kidney, stomach, and many others to occur.
Has There Been a Zantac Recall?
Zantac recalls have been sounded across the globe due to these revelations in the third-party testing laboratories. Health agencies across the world recalled and halted distribution of Zantac and ranitidine last Fall when the news broke. Ranitidine recalls due to cancer concerns led to some of the largest pharmaceutical companies in the world issuing recalls on their prescription Zantac, ranitidine, and over the counter products. April 1st, 2020 is the latest important date in the timeline of Zantac recall lawsuits. Millions of people who either were unaware of the recalls and studies revealing high levels of NDMA and those that were aware and continued to use the medication anyway would no longer be able to purchase and use the drug.
How do I Know if I’m Eligible to File a Lawsuit Against Zantac?
Zantac cancer claims are being filed against the manufacturers of these bad drugs. Design defects and failure to warn of the cancer danger are being alleged against Sanofi, Sandoz Inc, Apotex, and numerous other drug manufacturers. The FDA does not believe you are at risk of cancer if you took the drug for a short period of time and were only exposed to low levels of NDMA. For those that were prescribed Zantac for many months and years, there may be an appreciable increase in the risk of cancer forming due to consistently high levels of NDMA exposure, especially if the manufacturer was negligent in the way they produced the drug.
If Zantac was produced in a hot factory, there is a significant increase in the likelihood that the medication will contain higher than acceptable NDMA levels. Again, there is a risk of NDMA levels further increasing as the drug travels from the factory to the pharmacy shelf. Finally, there is another level of potential for an increase in NDMA levels when the drug travels from the store to the user’s home.
Depending on the storage conditions at that person’s home, higher temps may further increase the levels of NDMA over time, creating a heartburn medication that when ingested, already has many times the acceptable limit of NDMA before it ever enters the body. The most recent press release on April 1st confirmed the worst of fears as the FDA stated it confirmed that NDMA levels increase in ranitidine even under normal storage conditions.
Zantac lawsuits claim high levels of NDMA can increase the risk of bladder, stomach, kidney, and other cancers. Organs potentially affected by NDMA include the bladder, brain, liver, kidneys, lungs, and stomach according to the World Health Organization. The plaintiffs allege that the defendant drug companies failed to properly warn the public and users of the dangers of NDMA and cancer in their products.
They also allege the inherent instability of the drug is a design defect and the drug companies knew about NDMA for years without taking ranitidine off the market. It is arguable the drug companies were aware of several studies discussing the dangers of NDMA formation in Zantac all the way back into the 1980s and the potential for even further NDMA increases when ranitidine reacts with stomach acids and nitrites inside the body. There are even studies that show NDMA may be able to form when ranitidine is exposed to drinking water that contains chlorine as a disinfectant.
Proven Zantac use by pharmacy records, prescriptions, or other medical records and a cancer diagnosis is essential to the plaintiff’s chances for success in a claim against the drug manufacturers. The length and amount of usage is important as is the type of cancer the user has been diagnosed with. Currently, the types of Zantac cancer cases we are looking into include: stomach or gastric cancer, intestine, colorectal cancer, bladder cancer, esophageal cancer, liver cancer, and kidney cancer associated with NDMA in Zantac and ranitidine.
Zantac Class Action Lawsuit
There are also ranitidine class action suits being filed for other people who have purchased the medication. These Zantac and ranitidine class action suits serve to help those purchasers get their money back. Anyone who bought generic ranitidine or prescription Zantac can join the class action without a cancer diagnosis. Instead of claiming individual injuries on behalf of each person joining the class, their lawsuits are based on the defectiveness of the drug and that they are entitled to a refund.
Speak to an Attorney About Filing a Zantac Cancer Lawsuit
The Houston personal injury lawyers at the Willis Law Firm are currently filing individual Zantac & Ranitidine personal injury cases on behalf of clients who took these drugs and were diagnosed with one of the associated cancers. If you took Zantac or ranitidine and were later diagnosed with cancer, you may be entitled to a significant recovery for the damage caused by the drug company.
Call 713-LAWYERS or chat with one of our staff in the chatbox on this page for a completely private and confidential case evaluation to help determine if a Zantac cancer lawsuit is the right decision for you and your family.